Myocardial infarction does not further impair renal damage in 5/6 nephrectomized rats (Q46575615)

23 December 2017

title

Myocardial infarction does not further impair renal damage in 5/6 nephrectomized rats (English)

1 reference

23 December 2017

main subject

myocardial infarction

1 reference

1 reference

23 December 2017

author name string

Willemijn A K M Windt

1 reference

23 December 2017

Alex C A Kluppel

1 reference

23 December 2017

Ying Xu

1 reference

23 December 2017

Dick de Zeeuw

1 reference

23 December 2017

Richard P E van Dokkum

1 reference

23 December 2017

language of work or name

English

0 references

publication date

25 May 2008

1 reference

23 December 2017

Nephrology Dialysis Transplantation

published in

1 reference

23 December 2017

volume

1 reference

23 December 2017

issue

1 reference

23 December 2017

page(s)

3103-3110

1 reference

23 December 2017

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

The severe cardiorenal syndrome: 'Guyton revisited'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

Increased infarct size in uremic rats: reduced ischemia tolerance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

Cardiomyocyte loss in experimental renal failure: prevention by ramipril

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

Development of renal disease in people at high cardiovascular risk: results of the HOPE randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: the data of the meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

Risk-Treatment Mismatch in the Pharmacotherapy of Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFN233

21 January 2018

Identifiers

DOI

10.1093/NDT/GFN233

1 reference

23 December 2017

1 reference

23 December 2017